Cyclin-dependent kinase inhibitor p18INK4c is involved in protective roles of heme oxygenase-1 in cisplatin-induced acute kidney injury

Wang,Liang; Zhang,Yi; Yuan,Li; Liu,Chunyan; Fu,Lili; Mei,Changlin

doi:10.3892/ijmm.2014.1828

Cyclin-dependent kinase inhibitor p18INK4c is involved in protective roles of heme oxygenase-1 in cisplatin-induced acute kidney injury

Authors:
- Liang Wang
- Yi Zhang
- Li Yuan
- Chunyan Liu
- Lili Fu
- Changlin Mei
View Affiliations

Affiliations: Department of Urology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116021, P.R. China, Department of Nephrology, Changzheng Hospital, Shanghai 200003, P.R. China
Published online on: July 1, 2014 https://doi.org/10.3892/ijmm.2014.1828
Pages: 911-917

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Experimental studies have demonstrated the protective effect of heme oxygenase (HO)-1 and cyclin‑dependent kinase inhibitors (CDKIs) in acute kidney injury (AKI), and it has been documented that some of the protective effect of HO-1 is mediated by CDKIs. However, the role of p18INK4c (p18), an inhibitor of CDK4 (INK4), which is a family member of CDKIs, has not been well characterized in kidney diseases. The aim of the present study was to demonstrate p18 protection from the relationship between p18 and HO-1 in cisplatin-induced AKI. Upregulation of p18 and HO-1 was demonstrated by quantitative polymerase chain reaction (qPCR) and western blotting in cisplatin-induced AKI in vitro and in vivo. The effect of HO-1 on p18 was determined by western blotting using the inducer and inhibitor of HO-1 in vitro. The potential effect of p18 on HO-1 in cisplatin‑induced AKI was examined by p18 gene knockout mice in vivo. The results showed that p18 and HO-1 were upregulated in cisplatin‑induced AKI in vitro and in vivo. Deletion of the p18 gene did not affect the basal and inducible expression of HO-1 in the AKI animals, while hemin (10 µM) and znpp (10 µM), the inducer and inhibitor, respectively, of HO-1, regulated p18 expression when incubated with the cells. The results indicated that p18 may play protective roles and may be associated with or partially account for the cytoprotective effects of HO-1 in cisplatin-induced AKI.

View Figures

View References

1	Abraham NG and Kappas A: Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 60:79–127. 2008. View Article : Google Scholar : PubMed/NCBI
2	Deshane J, Wright M and Agarwal A: Heme oxygenase-1 expression in disease states. Acta Biochim Pol. 52:273–284. 2005.PubMed/NCBI
3	Yoshida T and Kikuchi G: Sequence of the reaction of heme catabolism catalyzed by the microsomal heme oxygenase system. FEBS Lett. 48:256–261. 1974. View Article : Google Scholar : PubMed/NCBI
4	Liu Y, Moënne-Loccoz P, Loehr TM and Ortiz de Montellano PR: Heme oxygenase-1, intermediates in verdoheme formation and the requirement for reduction equivalents. J Biol Chem. 272:6909–6917. 1997. View Article : Google Scholar : PubMed/NCBI
5	Maines MD: The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 37:517–554. 1997. View Article : Google Scholar : PubMed/NCBI
6	Durante W: Heme oxygenase-1 in growth control and its clinical application to vascular disease. J Cell Physiol. 195:373–382. 2003. View Article : Google Scholar : PubMed/NCBI
7	Abraham NG and Kappas A: Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med. 39:1–25. 2005. View Article : Google Scholar : PubMed/NCBI
8	Immenschuh S and Ramadori G: Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol. 60:1121–1128. 2000. View Article : Google Scholar : PubMed/NCBI
9	Goodman AI, Olszanecki R, Yang LM, et al: Heme oxygenase-1 protects against radiocontrast-induced acute kidney injury by regulating anti-apoptotic proteins. Kidney Int. 72:945–953. 2007. View Article : Google Scholar : PubMed/NCBI
10	Agarwal A, Balla J, Alam J, Croatt AJ and Nath KA: Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int. 48:1298–1307. 1995. View Article : Google Scholar : PubMed/NCBI
11	Gonçalves GM, Cenedeze MA, Feitoza CQ, et al: The role of heme oxygenase-1 in rapamycin-induced renal dysfunction after ischemia and reperfusion injury. Kidney Int. 70:1742–1749. 2006.PubMed/NCBI
12	Katori M, Anselmo DM, Busuttil RW and Kupiec-Weglinski JW: A novel strategy against ischemia and reperfusion injury: cytoprotection with heme oxygenase system. Transpl Immunol. 9:227–233. 2002. View Article : Google Scholar : PubMed/NCBI
13	Nath KA, Balla G, Vercellotti GM, et al: Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest. 90:267–270. 1992. View Article : Google Scholar : PubMed/NCBI
14	Inguaggiato P, Gonzalez-Michaca L, Croatt AJ, Haggard JJ, Alam J and Nath KA: Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int. 60:2181–2191. 2001. View Article : Google Scholar : PubMed/NCBI
15	Gonzalez-Michaca L, Farrugia G, Croatt AJ, Alam J and Nath KA: Heme: a determinant of life and death in renal tubular epithelial cells. Am J Physiol Renal Physiol. 286:F370–F377. 2004. View Article : Google Scholar : PubMed/NCBI
16	Megyesi J, Safirstein RL and Price PM: Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest. 101:777–782. 1998. View Article : Google Scholar : PubMed/NCBI
17	Zhou H, Kato A, Yasuda H, et al: The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure. Toxicol Appl Pharmacol. 200:111–120. 2004. View Article : Google Scholar : PubMed/NCBI
18	Zhou H, Fujigaki Y, Kato A, et al: Inhibition of p21 modifies the response of cortical proximal tubules to cisplatin in rats. Am J Physiol Renal Physiol. 291:F225–F235. 2006. View Article : Google Scholar : PubMed/NCBI
19	Nowak G, Price PM and Schnellmann RG: Lack of a functional p21WAF1/CIP1 gene accelerates caspase-independent apoptosis induced by cisplatin in renal cells. Am J Physiol Renal Physiol. 285:F440–F450. 2003.PubMed/NCBI
20	Price PM, Safirstein RL and Megyesi J: Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol. 286:F378–F384. 2004. View Article : Google Scholar : PubMed/NCBI
21	Yu F, Megyesi J, Safirstein RL and Price PM: Identification of the functional domain of p21(WAF1/CIP1) that protects cells from cisplatin cytotoxicity. Am J Physiol Renal Physiol. 289:F514–F520. 2005. View Article : Google Scholar : PubMed/NCBI
22	Megyesi J, Andrade L, Vieira JM Jr, Safirstein RL and Price PM: Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure. Am J Physiol Renal Physiol. 283:F810–F816. 2002. View Article : Google Scholar : PubMed/NCBI
23	Miyaji T, Kato A, Yasuda H, Fujigaki Y and Hishida A: Role of the increase in p21 in cisplatin-induced acute renal failure in rats. J Am Soc Nephrol. 12:900–908. 2001.PubMed/NCBI
24	Nath KA: Provenance of the protective property of p21. Am J Physiol Renal Physiol. 289:F512–F513. 2005. View Article : Google Scholar : PubMed/NCBI
25	Hengst L and Reed SI: Inhibitors of the Cip/Kip family. Curr Top Microbiol Immunol. 227:25–41. 1998.
26	Sherr CJ and Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149–1163. 1995. View Article : Google Scholar : PubMed/NCBI
27	Zhang Y, Yuan L, Fu L, Liu C, Liu D and Mei C: Overexpression of p18INK4C in LLC-PK1 cells increases the resistance to cisplatin-induced apoptosis. Pediatr Nephrol. 26:1291–1301. 2011. View Article : Google Scholar : PubMed/NCBI
28	Yu F, Megyesi J and Price PM: Cytoplasmic initiation of cisplatin cytotoxicity. Am J Physiol Renal Physiol. 295:F44–F52. 2008. View Article : Google Scholar : PubMed/NCBI
29	Yuan Y, Shen H, Franklin DS, et al: In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat Cell Biol. 6:436–442. 2004. View Article : Google Scholar : PubMed/NCBI
30	Franklin DS, Godfrey VL, Lee H, et al: CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12:2899–2911. 1998. View Article : Google Scholar : PubMed/NCBI
31	Shimizu H, Takahashi T, Suzuki T, et al: Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med. 28:809–817. 2000. View Article : Google Scholar : PubMed/NCBI
32	Shankland SJ and Wolf G: Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol. 278:F515–F529. 2000.PubMed/NCBI
33	Weinert T: DNA damage and checkpoint pathways: molecular anatomy and interactions with repair. Cell. 94:555–558. 1998. View Article : Google Scholar : PubMed/NCBI
34	Cánepa ET, Scassa ME, Ceruti JM, et al: INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life. 59:419–426. 2007.PubMed/NCBI
35	Shiraishi F, Curtis LM, Truong L, et al: Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol. 278:F726–F736. 2000.PubMed/NCBI
36	Park HM, Cho JM, Lee HR, Shim GS and Kwak MK: Renal protection by 3H-1,2-dithiole-3-thione against cisplatin through the Nrf2-antioxidant pathway. Biochem Pharmacol. 76:597–607. 2008. View Article : Google Scholar : PubMed/NCBI
37	Yoon HY, Kang NI, Lee HK, Jang KY, Park JW and Park BH: Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem Pharmacol. 75:2214–2223. 2008. View Article : Google Scholar : PubMed/NCBI
38	Gueler F, Park JK, Rong S, et al: Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. Am J Pathol. 170:1192–1199. 2007. View Article : Google Scholar : PubMed/NCBI
39	Watanabe M, de Moura Neiva LB, da Costa Santos CX, Martins Laurindo FR and de Fátima Fernandes Vattimo M: Isoflavone and the heme oxygenase system in ischemic acute kidney injury in rats. Food Chem Toxicol. 45:2366–2371. 2007. View Article : Google Scholar : PubMed/NCBI
40	Agarwal A and Nick HS: Renal response to tissue injury: lessons from heme oxygenase-1 GeneAblation and expression. J Am Soc Nephrol. 11:965–973. 2000.PubMed/NCBI
41	Zager RA: Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 49:314–326. 1996. View Article : Google Scholar : PubMed/NCBI
42	Hill-Kapturczak N, Chang SH and Agarwal A: Heme oxygenase and the kidney. DNA Cell Biol. 21:307–321. 2002. View Article : Google Scholar
43	Nath KA, Haggard JJ, Croatt AJ, Grande JP, Poss KD and Alam J: The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol. 156:1527–1535. 2000. View Article : Google Scholar : PubMed/NCBI
44	Abraham NG, Lin JH, Schwartzman ML, Levere RD and Shibahara S: The physiological significance of heme oxygenase. Int J Biochem. 20:543–558. 1988. View Article : Google Scholar : PubMed/NCBI
45	Miralem T, Hu Z, Torno MD, Lelli KM and Maines MD: Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. J Biol Chem. 280:17084–17092. 2005. View Article : Google Scholar
46	Motterlini R: Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. Biochem Soc Trans. 35:1142–1146. 2007. View Article : Google Scholar : PubMed/NCBI